BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fan L, Liu WC, Zhang YJ, Ren J, Pan BR, Liu DH, Chen Y, Yu ZC. Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies. World J Gastroenterol 2005; 11(28): 4300-4304 [PMID: 16038024 DOI: 10.3748/wjg.v11.i28.4300]
URL: https://www.wjgnet.com/1007-9327/full/v11/i28/4300.htm
Number Citing Articles
1
Jiayi Chen, Chenhong Qian, Peng Ren, Han Yu, Xiangjia Kong, Chenglong Huang, Huanhuan Luo, Gang Chen. Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma SuppressionFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.679610
2
Y.G. Lin, M. Deavers, F. Sasan, J.S. Zager, L.M. Ramondetta. Clinical challenges presented by three simultaneous solid tumorsGynecologic Oncology 2006; 103(3): 1159 doi: 10.1016/j.ygyno.2006.08.050
3
Di-nuo Li, Liang Wang, Lei Wang, Shen Li, Yu-bing Wang. Expression of Inhibitor of Differentiation-1 and Its Effects on Angiogenesis in Gastric CancerCancer Biotherapy and Radiopharmaceuticals 2016; 31(7): 233 doi: 10.1089/cbr.2016.2043
4
Muhammad Wasif Saif, Nikos A. Katirtzoglou, Kostas N. Syrigos. Capecitabine: an overview of the side effects and their managementAnti-Cancer Drugs 2008; 19(5): 447 doi: 10.1097/CAD.0b013e3282f945aa
5
Fiona Chionh, David Lau, Yvonne Yeung, Timothy Price, Niall Tebbutt. Oral versus intravenous fluoropyrimidines for colorectal cancerCochrane Database of Systematic Reviews 2017; 2017(8) doi: 10.1002/14651858.CD008398.pub2
6
Patrícia Andréa Crippa Marques, Angela Maria Geraldo Pierin. Factors that affect cancer patient compliance to oral anti-neoplastic therapyActa Paulista de Enfermagem 2008; 21(2): 323 doi: 10.1590/S0103-21002008000200015